Literature DB >> 2492898

Histologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy.

O M Braun1, B Neumeister, W Popp, R Scherrer, E Dobrowsky, W Dobrowsky, E M Rausch, H Strassl, K Krisch, J H Holzner.   

Abstract

Forty-one patients with Stage III and IV squamous cell carcinomas (SCC) of the head and neck were treated preoperatively with mitomycin C and 5-fluorouracil and concomitant radiotherapy. Operation specimen were examined histologically, the percentage of vital tumor cells and devitalized tumor cells were graduated. The grade of regression was classified according to a four-stage scale. Tumor regression was elevated as good (Grades 1, 2) and bad (3, 4) response to combined preoperative therapy. After a follow-up of 18 to 30 months, 14 of 41 patients have experienced a locoregional recurrence; all these patients were bad responders (Grades 3, 4) to preoperative radiochemotherapy. There was a statistically significant correlation between tumor regression grade and probability of survival (P less than 0.001). The authors conclude that the prognosis of patients with pretreated SCC of head and neck depends on the histologic grade of tumor regression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492898     DOI: 10.1002/1097-0142(19890315)63:6<1097::aid-cncr2820630610>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Postoperative failure of platelet recovery is an independent risk factor for poor survival in patients with oral and oropharyngeal cancer.

Authors:  Christos Perisanidis; Martina Mittlböck; Alexandra Schoppmann; Gabriela Kornek; Patrick Starlinger; Anton Stift; Edgar Selzer; Christian Schopper; Rolf Ewers
Journal:  Clin Oral Investig       Date:  2012-05-29       Impact factor: 3.573

2.  A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy.

Authors:  B Dunne; J V Reynolds; E Mulligan; A Kelly; M Griffin
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

3.  Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.

Authors:  G Francini; R Petrioli; A Aquino; S Gonnelli
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy.

Authors:  Oliver Driemel; Tobias Ettl; Oliver Kölbl; Torsten E Reichert; Bernd V Dresp; Jürgen Reuther; Hans Pistner
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

5.  Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer.

Authors:  Michael D Chuong; Jessica M Frakes; Nicholas Figura; Sarah E Hoffe; Ravi Shridhar; Eric A Mellon; Pamela J Hodul; Mokenge P Malafa; Gregory M Springett; Barbara A Centeno
Journal:  J Gastrointest Oncol       Date:  2016-04

6.  ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.

Authors:  Jiawang Wei; Rong Huang; Suping Guo; Xuhui Zhang; Shaoyan Xi; Qiaoxuan Wang; Hui Chang; Xiaohao Wang; Weiwei Xiao; Zhifan Zeng; Yuanhong Gao
Journal:  Cancer Manag Res       Date:  2018-10-31       Impact factor: 3.989

7.  Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.

Authors:  Jens von der Grün; Ria Winkelmann; Iris Burck; Daniel Martin; Franz Rödel; Peter Johannes Wild; Katrin Bankov; Andreas Weigert; Ivan-Maximiliano Kur; Christian Brandts; Natalie Filmann; Christian Issing; Philipp Thönissen; Anna Maria Tanneberger; Claus Rödel; Shahram Ghanaati; Panagiotis Balermpas
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

8.  Locally Advanced Oral Cavity Cancers: What Is The Optimal Care?

Authors:  Rajab Alzahrani; Arwa Obaid; Hadi Al-Hakami; Ahmed Alshehri; Hossam Al-Assaf; Reem Adas; Eman Alduhaibi; Nabil Alsafadi; Suliman Alghamdi; Majed Alghamdi
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

9.  Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.

Authors:  Sridhar Mishra; Vandna Tiwari; Aditi Arora; Seema Gupta; Nidhi Anand; Nuzhat Husain
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01

10.  Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.

Authors:  Lu-Ning Zhang; Wei-Wei Xiao; Shao-Yan Xi; Pu-Yun OuYang; Kai-Yun You; Zhi-Fan Zeng; Pei-Rong Ding; Hui-Zhong Zhang; Zhi-Zhong Pan; Rui-Hua Xu; Yuan-Hong Gao
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.